{"id":"W2752001050","doi":"10.1093/rheumatology/kex062.217","title":"216. BARICITINIB, METHOTREXATE, OR BARICITINIB PLUS METHOTREXATE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD RECEIVED LIMITED OR NO TREATMENT WITH DMARDS: EFFICACY AND SAFETY RESULTS FROM THE 52-WEEK PHASE 3 RA-BEGIN STUDY","year":2017,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada); McMaster University","funders":"","keywords":"Medicine; Methotrexate; Rheumatoid arthritis; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084219,0.0006247456,0.001982087,0.0002749132,0.0002715062,0.0006626181,0.0004462815,0.0009145832,0.004285607],"category_scores_gemma":[0.0008680298,0.0003782784,0.00124006,0.0003132758,0.000401936,0.0004870739,0.0002004268,0.001316874,0.001155968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003397606,"about_ca_system_score_gemma":0.0004946513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004261177,"about_ca_topic_score_gemma":0.001755144,"domain_scores_codex":[0.9996599,0.0001514283,0.00004111686,0.00005498162,0.00003593116,0.00005658402],"domain_scores_gemma":[0.9994136,0.0001500894,0.0001893414,0.00004269604,0.0000337853,0.0001705163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9142765,0.007473419,0.004221264,0.0009459607,0.001550818,0.0001471657,0.00006874244,0.0005779468,0.01205155,0.00006752054,0.001802874,0.05681617],"study_design_scores_gemma":[0.6950175,0.2802176,0.01810194,0.00009279239,0.001145063,0.0003253332,0.00003576169,0.0007752721,0.001951595,0.0001039878,0.002197772,0.00003535982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889169,0.006796797,0.0001936888,0.0003974733,0.0001566595,0.0006774241,0.0006258225,0.00006389604,0.002171291],"genre_scores_gemma":[0.9946983,0.001665967,0.0003596183,0.0005242658,0.0001667613,0.0004114552,0.0007877108,0.000009581307,0.001376371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004285607,"threshold_uncertainty_score":0.01433676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05011338968214165,"score_gpt":0.3321491705360243,"score_spread":0.2820357808538827,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}